Kinetic studies of the pyruvate kinases of rat and human tissues have led to the identification of three classes of isoenzymes with qualitative differences in regulatory properties.
the weak isosteric inhibition of muscle pyruvate kinase by L-or D-alanine as analogue of the product.
The allosteric inhibition of pyruvate kinase L by ATP is highly specific in contrast with a rather wide specificity of this enzyme for nucleoside diphosphates as acceptor substrates.
Evidence for the occurrence of several isoenzymes of pyruvate kinase in higher animals, particularly in the rat, has been reported from several laboratories [I--31. While most of the classifications have been based on electrophoretic evidence, a marked contrast in regulatory properties of the major component of pyruvate kinase activity in liver ("L") with respect to the older known muscle enzyme ("M") has also been amply demonstrated [2,4-81. A systematic screening for key kinetic properties of the pyruvate kinase activity in certain rat tissues and fractions, prompted by the interest in the physiological significance of the potential control of the pyruvate kinase reaction in different types of metabolism, has given results which indicate that there are a t least three classes of isoenzymes of pyruvate kinase differing in regulatory properties in rat and human tissues: the highly regulatable class L, the apparently unsophisticated class hl, and a regulatable class of intermediate complexity, inhibited by alanine and activated by
Abbreviations. Fru-P,, fructose 1,6-bisphosphate; P-pyEnzyme. Pyruvate kinase (EC 2.7.1.40).
ruvate, phosphoenolpyruvate. fructose 1,6-bisphosphate, which we propose to designate as class "A" because it was first observed in adipose tissue [911. Class A, rather than M as formerly reported, is the major component of the pyruvate kinase activity in kidney extracts and the minor one in liver extracts. A comparative study ofthe allosteric properties of the classes A and L from kidney and liver is also reported here.
MATERIALS AND METHODS
Wistar rats fed on a standard laboratory diet were used. Tissues were homogenized in the cold (2-4 "C) with 3 vol. of 0.25 M sucrose (except in the case of adipose tissue where 7 vol. was used) in a Kontes Dual-Grinder homogenizer, or, for the muscular tissues, a Virtk homogenizer. A sample of human liver from a surgical biopsy was obtained from Dr V. Rojo (Centro Nacional de Investigaciones MBdico-Quirdrgicas de la Seguridad Social, Madrid). The homogenates were centrifuged at 30000 x g for 30 min. Ammonium sulphate fractionation of tissue extracts was carried out by addition, to the latter, of a saturated solution of ammonium sulphate (at 2-4 "C, neutralized) to give the desired percentage saturations. The 30 to 45O/, and the 55 -70°/,aaturation precipitates, collected by centrifugation a t 20000 xg for 15 min, were dissolved in 25mM Tris-HC1 pH7.4 containing 0.1 mM EDTA and 1 mM dithioerythritol and dialyzed for 2 h against the same mixture. The 30 to 4501, fraction was routinely preincubated 5 min at 38 "C just before assay [8] .
Pyruvate kinase activity was assayed spectrophotometrically following the decrease in absorbance a t 340 nm, a t room temperature (approx. 25 "C) in a reaction mixture containing, unless indicated otherwise, 60 mM imidazole-HC1 pH 7.0, 0.1 M KC1, 5 mM MgCl,, 0.15 mM NADH, 1 mM MgADP, 1 U/ml lactate dehydrogenase, and 5 mM phosphoenolpyruvate. Standard concentrations of potentially regulatory metabolites added were 2 mM for alanine and MgATP and 10 pM for FN-P,.
Amino acids were of the L-series, unless indicated otherwise. They were obtained from Calbiochem, Mann, Fisher and Sigma. Muscle pyruvate kinase and auxillary enzymes were obtained from Boehringer. Nucleotides were obtained from Sigma, except CDP which was from Boehringer. that the enzyme from adipose tissue [9] and kidney extracts was strongly inhibited by alanine but not by ATP. A combination of alanine and cold pretreatment [S] has led to the distribution of major tissues of the rat in three groups. As shown in Fig. 1 , the pyruvate kinase activity in liver extracts is strongly inhibited by 2 mM alanine, a t moderate concentrations of phosphoenolpyruvate if the extract is preincubated a t 37 "C before the assay; kidney and adipose tissue extracts are inhibited by alanine irrespective of temperature and skeletal muscle and brain (as well as heart and uterus) extracts are never inhibited by 2 mM alanine. Liver and kidney extracts were fractionated by precipitation with ammonium sulphate to separate the two isoenzymes known to occur in each of these tissues, and the fractions corresponding to the two isoenzymes were characterized with respect to allosteric properties by the use of a few purposely selected experimental conditions. The results in In contrast, the higher ammonium sulphate fraction of both tissues, is inhibited by alanine but not by ATP, is activated by Fru-P,, and exhibits slight cooperativity with respect to phosphoerwlpyruvate in the absence of alanine. The effect of the concentration of alanine on the inhibition of pyruvate kinase in the two higher ammonium sulphate fractions of liver and kidney and in tissue extracts is shown in Fig.2 . In the three cases the effect of the concentration of alanine on the activity with 0.5 mM phosphoerwlpyruvate reached 50°/, inhibition at about 0.lmM and was about g o o / , at 5 mM. These results suggest that the three cases involve the same type of regulatory, isoenzyme of pyruvate kinase, which henceforth will be designated as class A. This conclusion is rcinforced by other kinetic parallelism between the major component of kidney extracts and the minor one of liver extracts that will be reported below, but leaves quite open the possibility of each class involving several individual isoenzymes that could differ in other properties. [S] showed that the strong inhibition of pyruvate b a s e L by ATP started without detectable lag and disappeared on removal of ATP with an enzymatic trap. Fig. 3 shows that the inhibition of pyruvate kinases L and A by alanine and its counteraction by Fru-P, also appear and disappear very rapidly after addition and removal, respectively. The marked transition visible in the figure after the Fru-P, trap corresponds to the contribution of the enzymatic trap during the removal of Fru-P, ; because of the high affinity of the enzyme for Fru-P,, the initial rate of NADH disappearance is increased since the Fru-P, trap is acting before the pyruvate kinase runs short of activator. Observations of Hess and Kutzbach [ll] on electrophoretic behaviour of pyruvate kinase L that suggested the possibility of considerable hysteresis in the disappearance of the conformational change induced by Fru-P, should be abscribed rather to the very high a f h i t y of the enzyme for Fru-P , when saturated with phosphoenolpyruvate. Table 2 it appears that there are three amino acids of particular interest: ctlanine, cysteine and phenylalanine. Stronger inhibitors than alanine are cysteine for pyruvate kinase L and phenylalanine for pyruvate kinase A. Some differences in apparent sensitivity according to the source of the enzyme preparation might not be significant because of the probability of some contamination, particularly with class A in the case of the lower ammonium sulphate fraction of rat kidney. The effect of the concentration of cysteine on the activity of pyruvate kinase L from rat liver is illustrated in Fig. 4 . At 0.25 mM phosphoenolpyruvate, as little as 0.06 mM cysteine is enough for 50°/, inhibition. The strong inhibition by cysteine is not shared by other compounds with free -SH groups, since neither dithioerythritol, glutathione, DL-homocysteine or even wcysteine, at 1 mM, were inhibitory in similar conditions. Fig.5 illustrates the strong inhibition of pyruvate kinase A by phenylalanine.
RESULTS

Effects of
The above three strongly inhibitory amino acids were assayed in pairs on the two classes of regulatory pyruvate kinases, as shown in Table 3 . With pyruvate kinase L the strong inhibition by either cysteine or alanine were not appreciably affected by equimolar phenylalanine. Nevertheless, with pyruvate kinase A, equimolar mixtures of either phenylalanine or alanine with cysteine were less inhibitory than the former amino acids alone. These observations might contribute to the ascertaining of the number of amino acid regulatory sites, which wiU be discussed below.
Differential stereospecificity eliminates the possibility that the inhibition by alanine of pyruvate kinases L and A could be related to the fact that alanine is a rather close structural analogue of the other product, pyruvate. The results in Table4 indicate that alanine is indeed a potential isosteric inhibitor of pyruvate kinase, but that there are drastic differences both quantitative and qualitative between the strong and stereospecific inhibition of pyruvate b a s e L (as well as that of type A, not included in the Table) by L-alanine. and the weak isosteric inhibition of pyruvate kinase M by either L-or D-alanine. The inhibitions by phenylalanine and cysteine are also stereospecific for the L-isomer and can be counteracted by low concentrations of Fru-Pz.
Allosteric Inhibition of Pyruvate Kinuse L by A T P
The strong inhibition by ATP of native pyruvate kinase L has been reported to be an allosteric effect subject to reversible desensitization [S]. Nucleotide specilkity studies with the 30-45°/, ammonium sulphate fraction of rat liver, fully confirm this conclusion, since there is a marked difference between a wide specificity for nucleoside diphosphates as acceptors (ADP, GDP, UDP, and IDP) and a narrow one for Fru-P, reversible inhibition by nucleoside triphosphates, which is highly specific for ATP ( Table 5) . This observation fulfills a major requirement of those outlined by Sols [I21 to identify as allosteric certain effects by primary products. Although this allosteric inhibition can be reversed by increasing the concentration of phosphoenolpyruvate it is not related to the inhibition of muscle pyruvate kinase, well characterized by Reynard et aE.
[13] as competitive respect to both ADP and phosphoenolpyruvate because of steric hindrance on the active subsites.
The lack of significant allosteric inhibition by ATP of 6he class A isoenzyme has been substantiated in several ways. Lowering the phosphoenolpyruvate concentration to 0.1 mM, while increasing the inhibition of pyruvate kinase activity in a kidney extract by 2 mM alanine to about 95O/,, gave only a weak Characterization of Classes L and A of Pyruvate Kinase in Human Liver A sample of human liver obtained by surgical biopsy was homogenized and the extract fractionated with ammonium sulphate essentially as indicated in Materials and Methods. Fig.7 gives the kinetic characterization of the 25 -45O/, ammonium sulphate fraction. The following [S],., and n (Hill coefficient) values for phosphoenolpyruvate were calculated : without additions, 0.2 mM and 1.9 ; with 2 mM MgATP, 0.4 mM and 3.3; with 2 mM alanine, 0.7 mM and 3.6; with 2 mM cysteine, 1.1 mM and x4.0; and with 10pM Fru-PZ, (0.05mM. These results correspond to pyruvate kinase of the L class, as defined above.
The kinetic characterization of the 55 -75O/, ammonium sulphate fraction is summarized in Table 6 . The results clearly indicate that human liver, like that of the rat, contains, in addition to a class L pyruvate kinase, a class A isoenzyme which is allosterically inhibitable by alanine (and phenylalanine) but not by MgATP, and which is strongly activable by Fru-P,. 
DISCUSSION
The increasing number of recognizable distinct forms of pyruvate kinase in animal tissues [15-171 makes it convenient for studies of metabolic control at the enzyme level to group them in classes according to regulatory properties. The present work gives evidence that in higher animals there are a t least three classes of isoenzymes of pyruvate kinase differing in regulatory properties in a well-defined and consistent pattern. These classes are not mere conformational varieties of a given isoenzyme [l I]. On the contrary, each of these classes includes, or might include, several different isoenzymes, even in Table 6 . Allosteric daractei-izalion as class A of the pjmvate kinase activity in the 55--75O/, ammonium sulphate fraction of human liver A human liver sample was homogenized, fractionated and assayed essentially as described in Materials and Methods with 0.25 mM P-pyruvate and additions as indicated Of the three classes, two have well-defined allosteric properties suitable for metabolic control in physiological conditions. These two, the L and A classes, share a number of regulatory properties but difler in the allosteric inhibition by ATP, which occurs in class L but not in class A. ATP as a primary product of the pyruvate kinase reaction in its physiological direction is an isosteric inhibitor, as shown by Reynard et al. [13] with the muscle enzyme. The 1, class is not merely more sensitive to the same type of inhibition but has a specific mechanism for inhibition by ATP which is clearly allosteric on the basis of the convergence of the following criteria, for ATP between muscle pyruvate kinase and the non-L component in liver extracts [18] are not likely to involve any s i g d c a n t non-isosteric component.
The difference between the A and the L classes of isoenzymes of pyruvate kinase implies more than the restriction to the latter of the allosteric inhibition by ATP. Although these two regulatory isoenzymes are both allosterically inhibited by alanine within the physiological range of concentrations, there are marked differences in the specificity of inhibition by amino acids. Class L is more sensitive to inhibition by cysteine than by alanine and much less sensitive to phenylalanine, while class A is more strongly inhibited by phenylalanine and only weakly by cysteine. The results do not permit a conclusion as to whether a single site with a different specificity pattern in each class of isoenzyme accounts for all these inhibitions or if two or three different amino acid inhibition sites are involved in each isoenzyme. The fact that serine is appreciably inhibitory for class LI, which is the ones tronglyinhibited by cysteine and the behaviour of mixtures of amino acids ( Alanine is the predominant amino acid going from muscle to liver in fasted animals [31] , partly substituting for lactate in the classical Cori cycle. It has been characterized as a major precursor of carbon skeletons for gluconeogenesis [32, 33] . Also, it has been found to be a powerful stimulant of glucagon secretion [24] . These facts make alanine a most suitable candidate for the negative control of pyruvate kinase activity essential to prevent large-scale diversion of phosphoenolpyruvate in gluconeogenesis.
We have no plausible explanation for the occurrence of two different classes of allosteric, alanineinhibitable, fructose-bis-phosphate-activatable pyruvate kinases in animal tissues, nor for the occurrence of a regulatable pyruvate kinase in non-gluconeogenic tissues. A similar problem concerns phosphoenolpyruvate carboxykinase in these tissues. For adipose tissue the suggestion has been made that it could be related to glycerogencsis involving the lower part of the "gluconeogenic pathway", although the large excess of pyruvate kinase makes unlikely an efficient control of its activity for such a purpose. And not even such a hypothetical role is apparent for the non-parenchymal cells of the liver, where the p puvate kinase seems to be also of class A [35,36]. It might not be fortuitous that there is apparent paralellism between the distribution of a regulatable pyruvate kinase and that of phosphoenolpyruvate carboxykinase, well characterized in adipose tissue and whose absence in skeletal muscle seems also well established. Glutamate, glutamine, aspartate and asparagine constitute about one fourth of the protein pool that can lead to intermediate of the Krebs cycle through the action of glutamate dehydrogenase, glutamic oxalacetic transaminase, the urea cycle, and the purine nucleotide cycle [37] . For substantial use of these carbon skeletons for energy or fatty acid synthesis there is need of an ancillary pathway to acetyl-CoA. The pair phosphoenolpyruvate carboxykinase -pyruvate kinase can insure such a conversion by an NADPH-independent system. One is tempted to speculate that once regulatable as well as non-regdatable classes of pyruvate kinase have been established in an organism, the former could be located in the genome in such relation to phosphoenolpyruvate carboxykinase that express- ibility of the latter in certain tissues would tend to be accompanied precisely by that of a regdatable pyruvate kinase, regardless of its ultimate value in a given tissue. In any case the occurrence of a regulatable pyruvate kinase in these tissues might be useful to buffer the levels of glycolytic intermediate from 
